Thus, one can speculate that most tumor infiltrated PD-1+ T cells could be specific for lymphoma cells, and present tumor-associated antigen, but fail to be activated properly by the PD-1/PD-L1 pathway, resulting in the immune evasion of BLV-induced lymphoma cells. This evidence concerns the gene CD274 and lymphoma.